CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,224,000 | +41.8% | 574,029 | +43.5% | 2.93% | +12.2% |
| Q1 2022 | $10,028,000 | +37.7% | 400,000 | +100.0% | 2.61% | +29.5% |
| Q4 2021 | $7,282,000 | +41.9% | 200,000 | -33.3% | 2.02% | +36.6% |
| Q3 2021 | $5,130,000 | +119.0% | 300,000 | +71.4% | 1.48% | +128.7% |
| Q2 2021 | $2,343,000 | -70.5% | 175,000 | +12.9% | 0.64% | -71.6% |
| Q1 2021 | $7,942,000 | -28.7% | 155,000 | -13.9% | 2.27% | -31.6% |
| Q4 2020 | $11,146,000 | +9.9% | 180,000 | -2.7% | 3.32% | +6.9% |
| Q3 2020 | $10,138,000 | +17.5% | 185,000 | +23.3% | 3.10% | +20.0% |
| Q2 2020 | $8,631,000 | +13.1% | 150,000 | -21.1% | 2.58% | -23.1% |
| Q1 2020 | $7,634,000 | +285.9% | 190,000 | +280.0% | 3.36% | +336.8% |
| Q4 2019 | $1,978,000 | – | 50,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |